Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age. (Q43980727)

28 November 2017

0 references

Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age. (English)

1 reference

28 November 2017

Peter Creticos

1

1 reference

28 November 2017

Katharine Knobil

2

1 reference

28 November 2017

Lisa D Edwards

3

1 reference

28 November 2017

Kathleen A Rickard

4

1 reference

28 November 2017

Paul Dorinsky

5

1 reference

28 November 2017

publication date

1 April 2002

1 reference

Annals of Allergy, Asthma & Immunology

28 November 2017

published in

1 reference

28 November 2017

volume

88

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

401-409

1 reference

Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Predictors of asthma severity in the elderly: results of a community survey in Northeast England

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Is asthma in the elderly really different?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Treatment of asthma with drugs modifying the leukotriene pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

The effect of inhaled budesonide on the maximal degree of airway narrowing to leukotriene D4 and methacholine in normal subjects in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Glucocorticosteroids inhibit leukotriene production

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Inhibition of cPLA2 translocation and leukotriene C4 secretion by fluticasone propionate in exogenously activated human eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Inhibition of human basophil leukotriene release by antiinflammatory steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Inhibition of eicosanoid biosynthesis by glucocorticoids in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

In vivo effect of prednisolone on release of leukotriene C4 in eosinophils obtained from asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Inhibitory effects of theophylline, terbutaline, and hydrocortisone on leukotriene B4 and C4 generation by human leukocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

A novel pharmacologic action of glucocorticosteroids on leukotriene C4 catabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Lung function in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Host factors affecting longitudinal decline in lung spirometry among grain elevator workers.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Asthma in the elderly. A comparison between patients with recently acquired and long-standing disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Peripheral mononuclear leucocyte beta adrenoceptors and non-specific bronchial responsiveness to methacholine in young and elderly normal subjects and asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

Reduced β-adrenergic receptor concentrations in ageing man

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962372-1

7 January 2021

10.1016/S1081-1206(10)62372-1

Identifiers

DOI

1 reference

28 November 2017

1 reference